• Adedayo Onitilo MD, PhD, MSCR, FACP

  • Physician - Hematology/Oncology


    • Weston - Oncology
    • 3400 Ministry Parkway WES Weston, WI 54476

Education

2014:
PhD, University of Queensland, Brisbane, Queensland, Australia
2004:
MSCR, Master of Science in Clinical Science, Medical University of South Carolina, Charleston, SC
2004:
Fellowship, Oncology/Hematology, Medical University of South Carolina, Charleston, SC
2001:
Residency, Internal Medicine, Columbia University College of Physicians & Surgeons, Harlem Hospital Center, New York, NY
1999:
Internship, Internal Medicine, Columbia University College of Physicians & Surgeons, Harlem Hospital Center, New York, NY
1998:
Clinical Experience, Medical Officer/ER Physician, The General Hospital, St. George and Princess Alice Hospital, St. Andrews, Grenada, West Indies
1997:
Internship, Rotations in Medicine, Pediatrics, Obstetrics & Gynecology and Surgery, General Hospital St. George's Grenada in affiliation with St. George's University School of Medicine, Grenada, West Indies
1996:
Internship, Rotations in Medicine and Pediatrics, Ogun State University Teaching Hospital, Sagamu, Nigeria
1995:
MD, Ogun State University, Sagamu, Ogun State, Nigeria

Work Experience

2017 to Present:
Oncologist / Hematologist, Marshfield Clinic Health System, Inc. Marshfield Medical Center - River Region at Stevens Point, Stevens Point, WI
2017 to Present:
Oncologist / Hematologist, Marshfield Clinic Health System, Inc. Marshfield Medical Center - Merrill, Merrill, WI
2015 to Present:
Principal Investigator, Wisconsin NCI Community Oncology Research Program (WiNCORP), Marshfield, WI
2015 to Present:
Oncology Research Director, Cancer Care and Research Center, Marshfield Medical Center-MCRI
2014 to Present:
Director, Oncology/Hematology, Radiation Oncology, and Palliative Medicine Service Line, Marshfield Clinic Health System, Inc. - Marshfield Medical Center - Marshfield, Marshfield, WI
2013 to Present:
Clinical Professor of Medicine, University of Wisconsin Medical School, Madison, WI
2010 to Present:
Chair, Hematology / Oncology Department, Marshfield Clinic, Inc., Eastern Division
2009 to Present:
Mentor, Physician Mentorship Program, Marshfield Clinic, Inc., Weston, WI
2007 to Present:
Associate Editor, Clinical Medicine and Research, Marshfield Clinic, Inc. - Marshfield Center, Marshfield, WI
2007 to Present:
Director, Breast Program, Marshfield Clinic Inc., Eastern Division, WI
2005 to Present:
Oncologist / Hematologist, Marshfield Clinic Health System, Inc. Marshfield Medical Center - Weston, Weston, WI
2005 to Present:
Attending Physician, MCHS Hospitals Inc. d/b/a Marshfield Medical Center
2005 to 2020:
Oncologist / Hematologist, Ascension Saint Clare's Hospital, Weston, WI
2005 to 2017:
Attending Physician, Ascension Saint Michael's Hospital, Stevens Point, WI
2014 to 2015:
Co-Investigator, Wisconsin NCI Community Oncology Research Program (WiNCORP), Marshfield, WI
2009 to 2014:
Co-Investigator, Community Oncology Research Program (CCOP), Marshfield, WI
2005 to 2013:
Clinical Assistant Professor of Medicine, University of Wisconsin Medical School, Madison, WI
2005 to 2012:
Assistant Director of Clinical Research, Marshfield Clinic Research Foundation, Eastern Division
2004 to 2007:
Oncologist / Hematologist, Wausau Hospital, Wausau, WI
2004 to 2005:
Oncologist / Hematologist, Marshfield Clinic Health System, Inc. Marshfield Medical Center - Wausau, Wausau, WI

Board Certifications

2002 to 2022:
American Board of Internal Medicine - Internal Medicine - Maintenance of Certification (MOC)
2004 to 2023:
American Board of Internal Medicine - Hematology - Maintenance of Certification (MOC)
2004 to 2023:
American Board Internal Medicine - Medical Oncology - Maintenance of Certification (MOC)

Honors & Awards

2014 to 2014:
Marshfield Clinic, Gwen D. Sebold Fellowship for Outstanding Research Award
2017 to 2018:
NCI Community Oncology Research Program (NCORP) Gold Certificate of Excellence
2018 to 2019:
NCI Community Oncology Research Program (NCORP) Principal Investigator Top Treatment Trial Accrual Award
2021 to 2021:
Marshfield Clinic, C. Todd Stewart Clinical Excellence Award
2016 to Present:
Marshfield Clinic, Ebenreiter Distinguished Physician/Scientist Endowment

Statement

"Patients always come first for me. I treat everyone as relatives and friends. I will give everyone my best, every time, every day!"

Professional Societies

American Academy of Hospice and Palliative Medicine, Member
American College of Physicians, Member
American Medical Association, Member
American Society of Clinical Oncology, Member
American Society of Hematology, Member
Grenadian Medical Association, Member
International Society of Experimental Hematology, Member
Nigerian Medical Association, Member
South Carolina Medical Association, Member
Society of General Internal Medicine, Member

Committees

2009 to 2010:
HMORN, Cancer Research Network Scholar
2013 to 2015:
Wisconsin Cancer Council (WCC), President
2018:
NCI NCORP Disparity Integration Committee, Member
2018:
Lung Committee, SWOG Research Base, Member
2012 to 2018:
Wisconsin Cancer Reporting System (WCRS) Data Quality Task Force, Member
2017 to 2018:
Thoracic Committee, ECOG-ACRIN Research Base, Member
2019 to 2023:
Governing Member, SWOG Cancer Research Network's Board of Governors (BOG) , Member
2020 to 2023:
American Society of Clinic Oncology (ASCO), Member
2006 to Present:
Marshfield Clinic Cancer Research Network (MC, CRN), Co-Investigator
2006 to Present:
Consortium on Breast Cancer Pharmacogenomics (COBRA), Member
2008 to Present:
Personalized Medicine Research Project (PMRP), Co-Investigator
2008 to Present:
Wisconsin Oncology Network (WON), Principal Investigator
2009 to Present:
Community Clinical Oncology Program (CCOP), Co-Investigator
2010 to Present:
American Cancer Society, Wisconsin State Leadership Council, Member
2010 to Present:
Wisconsin Cancer Council, Steering Committee Member
2020 to Present:
National Cancer Institute (NCI) Ad Hoc Working Group , Member

Presentations

2024:
Influence of aging, comorbidities, and chemotherapy on dementia in patients with metastatic cancer, American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
2024:
Importance of information-seeking styles among patients with cancer pre- and post- treatment: A URCC NCORP Research Base study, American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
2024:
Trauma, metastatic cancer, and physical abuse: Unveiling the interplay of risk factors in a nationwide analysis, Health Care Systems Research Network 2024 Conference
2024:
Impact of the COVID-19 pandemic mitigation strategies on cancer treatment trials: A meta-analysis of industry and NCI studies, American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
2024:
Longitudinal patterns of patient-reported cognitive impairment in Non-Hodgkin Lymphoma patients (NHL) treated with chemotherapy: A group-based trajectory analysis of a nationwide community-based cohort, American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

Select Publications

  • Onitilo AA. (1994). Social costs and medical benefits of genetic information on sickle-cell disease. Pugwash Guidebook.
  • Onitilo AA. (1998). Pernicious anemia presenting as fever, diarrhea, jaundice, anemia and hyperpigmentation. Grenada Medical Journal. 2 :1.
  • Onitilo AA, Olatosi AO, Igbal J, Capps LG. (2001 April). Preoperative cardiac risk assessment prior to ambulatory surgery. J Gen Int Med. 16(1):161.
  • Onitilo AA, Lazarchick J, Brunson CY, Frei-Lahr D, Stuart RK. Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma. Transplant Proc. 2003 December; 35(8):3089-3092.
    PubMed ID: 14697986
  • Kio EA, Onitilo AA, Lazarchick J, Hanna M, Brunson CY, Chaudhary BA. (2004 November). Sickle cell crisis associated with hemophagocytic lymphohistiocytosis. Am J Hematol. 77(3):229-232.
    PubMed ID: 15495257
  • Onitilo AA, Lin YH, Okonofua EC, Afrin LB, Ariail J, Tilley BC. Race, education, and knowledge of bone marrow registry: Indicators of willingness to donate bone marrow among African Americans and Caucasians. Transplant Proc. 2004 December; 36(10):3212-3219.
    PubMed ID: 15686731
  • Chaudhary UB, Rashid MH, Onitilo AA, Bissada NK. Secondary hormonal manipulations in the management of advanced prostate cancer. Can J Urol. 2005 June; 12(3):2666-2676.
    PubMed ID: 16011813
  • Onitilo AA, Kio EA, Singh AK, Lazarchick J. Cytogenetic remission with imatinib therapy in hypereosinophilic syndrome with trisomy 8 and resolution of severe cardiac dysfunction. Leuk Lymphoma. 2005 November; 46(11):1667-1670.
    PubMed ID: 16236620
  • Onitilo AA, Shaw GR. Parvovirus B19 infection in an isolated pancreas transplant recipient. Transplant Proc. 2005 December; 37(10):4433-4435.
    PubMed ID: 16387138
  • Onitilo AA, Skorupa A, Lal A, Ronish E, Mercier RJ, Islam R, Lazarchick J. Rituximab in the treatment of acquired factor VIII inhibitors. Thromb Haemost. 2006 July; 96(1):84-87.
    PubMed ID: 16807656
  • Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006 September; 28(5):396-402.
    PubMed ID: 16950374
  • Onitilo AA. Delayed profound thrombocytopenia associated with eptifibatide. Am J Hematol. 2006 December; 81(12):984.
    PubMed ID: 16804935
  • Onitilo AA, Engel JM, Olatosi B, Fagbemi SO. Community experience with bortezomib in patients with multiple myeloma. Am J Hematol. 2007 July; 82(7):637-639.
    PubMed ID: 17301970
  • Doi SA. R., Woodhouse NJ., Thalib L, Onitilo AA. (2007 June). Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited. Clin Med Res. 5(2):87-90.
    PubMed ID: 17607042
  • Huncharek MS, Muscat J, Onitilo AA, Kupelnick B. (2007 October). Use of cosmetic talc on contraceptive diaphragms and risk of ovarian cancer: a meta-analysis of nine observational studies. Eur J Cancer Prev. 16(5):422-429.
    PubMed ID: 17923813
  • Onitilo AA. (2007). Study examines breast cancer drug effectiveness. Personalized Medicine. 2(2):1, 4.
  • Onitilo AA, Kio EA, Doi SA. R.. Tumor-related hyponatremia. Clinical Medicine & Research. 2007 December; 5(4):218-26.
    PubMed ID: 18086907
  • Onitilo AA. Testicular microlithiasis: another starry sky appearance. Clinical Medicine & Research. 2007 September; 5(3):163-164.
    PubMed ID: 18056024
  • Onitilo AA, Engel JM, Demos JM, Mukesh BNanjan. Prognostic significance of (18) F-fluorodeoxyglucose positron emission tomography after treatment in patients with limited stage small cell lung cancer. Clinical Medicine & Research. 2008 September; 6(2):72 -77.
    PubMed ID: 18801952
  • Ghbeis M, Onitilo AA, Greenlee RT, Vidaillet HJ. (2008). Abstract 3131: Primary Cardiac Malignant Tumors. Incidence, Trends and Survival. CIRCULATION. 118(S):1098-S_1099.
  • Onitilo AA, Engel JM, Greenlee RT, Mukesh BNanjan. (2008 May). Breast cancer subtypes based on ER/PR and HER2 expression: A population-based experience. JOURNAL OF CLINICAL ONCOLOGY. May 20 suppl; abstr 22181
  • Engel JM, Onitilo AA, Demos JM, Mukesh BNanjan. (2008 May). Prognostic significance of (18) F-fluorodeoxyglucose positron emission tomography after treatment in patients with limited stage small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY. 26:2008(May 20 suppl; abstr 7591)
  • Onitilo AA, Engel JM. (2009 November). Managing Relapse of CML Using Therapeutic Imatinib Plasma Level Clin Adv Hematol Oncol. 7(11):763-7.
  • Onitilo AA, Engel JM, Greenlee RT, Mukesh BNanjan. (2009 June). Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival. Clin Med Res. 7(1-2):4-13.
    PubMed ID: 19251585
  • Doi SA. R., Onitilo AA. (2009 June). Author Reply Clinical Medicine & Research. 7(1-2):2-3.
  • Onitilo AA, Wilke RA, Glurich IE, Engel JM, Flockhart DA, Nguyen A,...Gin Y. Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. BREAST CANCER RESEARCH AND TREATMENT. 2009 June; 115(3):643-50.
    PubMed ID: 19082882
  • Onitilo AA, Engel JM, Lundgren CIhre, Hall P, Thalib L, Doi SA. R.. Simplifying the TNM system for clinical use in differentiated thyroid cancer. JOURNAL OF CLINICAL ONCOLOGY. 2009 April; 27(11):1872-8.
    PubMed ID: 19273697
  • Onitilo AA, Engel JM, Clouse LH, Gerndt KM. Successful Treatment of Mitomycin-induced Thrombotic Thrombocytopenic Purpura with Rituximab. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. 2009 February; 20(2):275-6.
    PubMed ID: 19054690
  • Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res. 2009 June; 7(1-2):4-13. PMCID: PMC2705275.
    PubMed ID: 19574486
  • Onitilo AA, Engel JM. Managing relapse of CML using therapeutic imatinib plasma level. Clin Adv Hematol Oncol. 2009 November; 7(11):763-7.
    PubMed ID: 20075835
  • Doi SA. R., Engel JM, Onitilo AA. Total thyroidectomy followed by postsurgical remnant ablation may improve cancer specific survival in differentiated thyroid carcinoma. Clin Nucl Med. 2010 June; 35(6):396-9.
    PubMed ID: 20479583
  • Feigelson HS, Bischoff K, Bowles E, Engel JM, James T, Onitilo AA,...McCahill L. (2010 December). PS2-24: Improving Breast Cancer Surgery Quality Through a Collaborative Surgical Database Clinical Medicine & Research. 8(3-4):180.
  • Onitilo AA, Engel JM, Resnick JM. Prostate carcinoma metastatic to the stomach: report of two cases and review of the literature. Clinical Medicine & Research. 2010 March; 8(1):18-21.
    PubMed ID: 20305145
  • Onitilo AA, Engel JM, Tanimu SB, Nguyen TT. (2010 Jul). Anthracosis and Large Mediastinal Mass in a Patient with Healed Pulmonary Tuberculosis. Clinical Medicine & Research. 8(2):99-103.
  • Feigelson HS, Goddard KA, Rahm A, Pawloski P, McCarty CA, Onitilo AA,...Potosky A. (2010 December). PS1-14: Utilization and Effectiveness of KRAS Testing for Colorectal Cancer Clinical Medicine & Research. 8(3-4):192.
  • Onitilo AA, Engel JM, Tanimu SB, Nguyen TC. Anthracosis and large mediastinal mass in a patient with healed pulmonary tuberculosis. Clin Med Res. 2010 July; 8(2):99-103. PMCID: PMC2910103.
    PubMed ID: 20660934
  • Onitilo AA, Engel JM, Sajjad SM. The possible role of hemochromatosis in testicular cancer. MEDICAL HYPOTHESES. 2011 August; 77(2):179-81.
    PubMed ID: 21549511
  • Delate T, Bowles E, Pardee R, Wellman R, Habel L, Yood M,...Wagner E [including McCarty CA, Onitilo AA.] (2011 November). C-C1-02: Validity of HMO Administrative Data for Breast Cancer Chemotherapy Exposure. Clinical Medicine & Research. 9(3-4):146.
  • Depke JL, Onitilo AA. Coalition building and the Intervention Wheel to address breast cancer screening in Hmong women. Clinical Medicine & Research. 2011 March; 9(1):1-9.
    PubMed ID: 21441527
  • Bowles E, Feigelson HS, Sterrett A, Barney T, Broecker K, Bischoff K,...McCahill L [including Engel JM, Onitilo AA.] (2011 November). PS2-03: Improving Quality Of Breast Cancer Surgery Through Development of a National Breast Cancer Surgical Outcomes Database. Clinical Medicine & Research. 9(3-4):144.
    PubMed ID: 22090527
  • Bowles E, Wellman R, Delate T, Allen L, Feigelson HS, Yood M,...Wagner E [including McCarty CA, Onitilo AA.] (2011 November). C-B2-01: Cardiotoxic Chemotherapy is Associated with Increased Heart Failure Risk Among Women with Breast Cancer in the Cancer Research Network Clinical Medicine & Research. 9(3-4):148.
  • Onitilo AA, Engel JM, Berg RL. (2011 November). C-B2-02: Epidemiology of Tamoxifen and Thromboembolism Clinical Medicine & Research. 9(3-4):150.
    PubMed ID: 22090543
  • Klimant E, Glurich IE, Mukesh BNanjan, Onitilo AA. Blood type, hormone receptor status, her2/neu status, and survival in breast cancer: a retrospective study exploring relationships in a phenotypically well-defined cohort. Clinical Medicine & Research. 2011 November; 9(3-4):111-8.
    PubMed ID: 21263059
  • Simpson M, Onitilo AA, Hocking WG, Mazza JJ. Anti-phospholipid antibodies in patients undergoing total joint replacement surgery. Thrombosis. 2012 October; 2012 :142615.
    PubMed ID: 23213505
  • Rocque G, Onitilo AA, Engel JM, Pettke E, Boshoven A, Kim K,...Burkard ME [including Waack B.] (2012 January). Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity. Breast Cancer Res Treat. 131(2):713-21.
    PubMed ID: 22065290
  • Delate T, Bowles E, Pardee R, Wellman R, Habel L, Yood M,...Wagner E [including Onitilo AA.] Validity of Eight Integrated Healthcare Delivery Organizations' Administrative Clinical Data to Capture Breast Cancer Chemotherapy Exposure. Cancer Epidemiol Biomarkers Prev.. 2012 April; 21(4):673-80.
    PubMed ID: 22337532
  • Onitilo AA, Demos JM, Depke JL, Resnick JM, Engel JM. (2012 June). Digital ischemia as a paraneoplastic consequence of squamous cell lung carcinoma. WMJ. 111(3):138-42; quiz 142.
  • Aiello Bowles E, Wellman R, Feigelson HS, Onitilo AA, Freedman A, Delate T,...for the Pharmacovigilance Study Team. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst.. 2012 August; 104(17):1293-305.
    PubMed ID: 22949432
  • Onitilo AA, Govinda A, Engel JM. Radiation-induced bronchiolitis obliterans organizing pneumonia: a case report and literature review. Clin Adv Hematol Oncol. 2012 October; 10(10):689-91.
    PubMed ID: 23187778
  • Feigelson HS, Onitilo AA, James T, Bowles EA, Single R, Barney T,...McCahill L [including Engel JM.] (2012 August). CA2-04: Variation in Mastectomy Rate for Invasive Breast Cancer: Results from the Breast Cancer Surgical Outcomes Study. Clinical Medicine & Research. 10(3):151-2.
    PubMed ID: 22904404
  • Onitilo AA, Engel JM, Feigelson HS, Bowles EA, Single R, James T, McCahill L. (2012 August). PS1-16: Patterns of Surgical Care for Ductal Carcinoma In-situ. Clinical Medicine & Research. 10(3):148.
    PubMed ID: 22904394
  • Goddard KA, Aiello Bowles E, Spencer Feigelson H, Habel LA, Alford S, McCarty CA,...Webster J [including Onitilo AA.] Utilization of HER2 genetic testing in a multi-institutional observational study. AMERICAN JOURNAL OF MANAGED CARE. 2012 November; 18(11):704-12.
    PubMed ID: 23198713
  • Onitilo AA. The debate over lifesaving benefit of screening mammography continues. ARCHIVES OF INTERNAL MEDICINE. 2012 March; 172(5):446-7.
    PubMed ID: 22412117
  • Bowles E, Feigelson HS, Barney T, Broecker K, Sterrett A, Bischoff K,...McCahill L [including Engel JM, Onitilo AA.] (2012 April). Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database. BMC CANCER. 12(1):136.
    PubMed ID: 22472011
  • Onitilo AA, Engel JM, Stankowski RV, Berg RL, Doi SA. R.. High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study. BREAST CANCER RESEARCH AND TREATMENT. 2012 July; 134(1):291-8.
    PubMed ID: 22476854
  • Onitilo AA, Engel JM, Glurich IE, Stankowski RV, Williams G, Doi SA. R.. Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. CANCER CAUSES & CONTROL. 2012 July; 23(7):991-1008.
    PubMed ID: 22527174
  • Onitilo AA, Engel JM, Glurich IE, Stankowski RV, Williams GH, Doi SA. R.. Diabetes and cancer I: risk, survival, and implications for screening. CANCER CAUSES & CONTROL. 2012 June; 23(6):967-81.
    PubMed ID: 22552844
  • McCahill L, Single R, Aiello Bowles E, Feigelson HS, James T, Barney T,...Onitilo AA [including Engel JM.] Variability in reexcision following breast conservation surgery. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2012 February; 307(5):467-75.
    PubMed ID: 22298678
  • Onitilo AA, Doi SA. R.. (2012 October). Recent data regarding low versus high 131I activity for remnant ablation in differentiated thyroid cancer are not generalizable beyond eligibility criteria. NUCLEAR MEDICINE COMMUNICATIONS. 33(11):1217-8.
  • Onitilo AA, Doi SA. R., Engel JM, Glurich IE, Johnson JC, Berg RL. Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: A population-based experience. THROMBOSIS RESEARCH. 2012 July; 130(1):27-31.
    PubMed ID: 22154240
  • Onitilo AA, Demos-Bertrand J, Depke J, Resnick JM, Engel J. Digital ischemia as a paraneoplastic consequence of squamous cell lung carcinoma. WMJ. 2012 June; 111(3):138-41; quiz 142.
    PubMed ID: 22870560
  • Onitilo AA, Doi SA. Recent data regarding low versus high 131I activity for remnant ablation in differentiated thyroid cancer are not generalizable beyond eligibility criteria. Nucl Med Commun. 2012 November; 33(11):1217-8.
    PubMed ID: 22996055
  • Onitilo AA, Engel JM, Salzman-Scott SA, Stankowski RV, Doi SA. R.. Reliability of reviewer ratings in the manuscript peer review process: an opportunity for improvement. Account Res. 2013 June; 20(4):270-84.
    PubMed ID: 23805832
  • Onitilo AA, Engel JM, Stankowski RV, Miskowiak D, Broton M, Doi SA. R.. Mammography Utilization: Patient Characteristics and Breast Cancer Stage at Diagnosis. AJR Am J Roentgenol. 2013 November; 201(5):1057-63.
    PubMed ID: 23952790
  • Liu J, Page D, Nassif H, Peissig PL, McCarty CA, Onitilo AA, Burnside E. Genetic variants improve breast cancer risk prediction on mammograms. AMIA Annu Symp Proc. 2013 November; 2013(eCollection 2013):876-85.
    PubMed ID: 24551380
  • Tanimu SB, Resnick JM, Onitilo AA. Peripancreatic cystic lymphangioma diagnosed by endoscopic ultrasound/fine-needle aspiration: a rare mesenchymal tumour. BMJ Case Rep. 2013 October; :pii: bcr2013200210.
    PubMed ID: 24092605
  • Doi SA. R., Barendregt JJ, Onitilo AA. Methods for the bias adjustment of meta-analyses of published observational studies. J Eval Clin Pract. 2013 August; 19(4):653-7.
    PubMed ID: 22845171
  • Webster J, Kauffman TL, Spencer Feigelson H, Pawloski PA, Onitilo AA, Potosky AL,...Goddard KA. KRAS Testing and Epidermal Growth Factor Receptor Inhibitor Treatment for Colorectal Cancer in Community Settings. Cancer Epidemiol Biomarkers Prev.. 2013 January; 22(1):91-101.
    PubMed ID: 23155138
  • Onitilo AA, Engel JM, Glurich IE. Long-Term Cardiac and Vascular Disease Outcomes Following Adjuvant Tamoxifen Therapy: Current Understanding of Impact on Physiology and Overall Survival, Minerva Medica. 2013 April; 104(2):141-53.
    PubMed ID: 23514990
  • Feigelson HS, James T, single RM, Onitilo AA, Aiello Bowles E, Barney T,...McCahill L. Factors Associated with the Frequency of Initial Total Mastectomy: Results of a Multi-Institutional Study. J Am Coll Surg. 2013 May; 216(5):966-75.
    PubMed ID: 23490543
  • Onitilo AA, Donald M, Stankowski RV, Engel JM, Williams G, Doi SA. R.. Breast and Prostate Cancer Survivors in a Diabetic Cohort: Results from the Living With Diabetes Study. Clinical Medicine & Research. 2013 December; 11(4):210-8.
    PubMed ID: 23669614
  • Onitilo AA, Berg RL, Engel JM, Stankowski RV, Glurich IE, Williams GA, Doi SA. R.. Prostate Cancer Risk in Pre-Diabetic Men: A Matched Cohort Study. Clinical Medicine & Research. 2013 December; 11(4):201-9.
    PubMed ID: 23656798
  • Glurich IE, Chyou P, Engel JM, Onitilo AA. Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association. Clinical Medicine & Research. 2013 February; 11(1):16-25.
    PubMed ID: 23411630
  • Onitilo AA, Aryal G, Engel JM. Hereditary Diffuse Gastric Cancer: A Family Diagnosis and Treatment. Clinical Medicine & Research. 2013 February; 11(1):36-41.
    PubMed ID: 22723466
  • Onitilo AA, Engel JM. A New NF1 Variant in a Patient with Atypical Manifestations. American Journal of Medical Genetics Part A. 2013 February; 161(2):389-92.
    PubMed ID: 23322702
  • Onitilo AA, Stankowski RV, Engel JM, Doi SA. R.. Adequate lymph node recovery improves survival in colorectal cancer patients. Journal of Surgical Oncology. 2013 June; 107(8):828-34.
    PubMed ID: 23592545
  • Rahm A, Kauffman TL, Webster J, Le A, Spencer Feigelson H, Alexander GL,...Goddard KA [including Onitilo AA.] Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. GENETICS IN MEDICINE. 2013 December; 15(12):933-40.
    PubMed ID: 23639899
  • Onitilo AA, Doi SA. R., Engel JM, Glurich IE, Berg RL. Relationship between Factor V Leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen. THROMBOSIS RESEARCH. 2013 June; 131(6):567-8.
    PubMed ID: 23497923
  • Onitilo AA, Berg RL, Engel JM, Glurich IE, Stankowski RV, Williams G, Doi SA. R.. Increased risk of colon cancer in men in the pre-diabetes phase. PLoS One. 2013 August; 8(8):E70426.
    PubMed ID: 23936428
  • Onitilo AA, Onesti J, Single R, Engel JM, James T, Aiello Bowles E,...McCahill L. (2013 December). Utilization of Neoadjuvant Chemotherapy Varies in the Treatment of Women with Invasive Breast Cancer PLoS One. 8(12):e84535.
  • Onitilo AA, Engel JM, James TA, Aiello Bowles EJ, McCahill LE, Feigelson HS. Reply: To PMID 23490543. J Am Coll Surg. 2013 November; 217(5):960-2.
    PubMed ID: 24139222
  • Onitilo AA, Onesti JK, Single RM, Engel JM, James TA, Aiello Bowles EJ,...McCahill LE. Utilization of neoadjuvant chemotherapy varies in the treatment of women with invasive breast cancer. PLoS One. 2013 December; 8(12):e84535. PMCID: PMC3869842.
    PubMed ID: 24376822
  • Braden AM, Stankowski RV, Engel JM, Onitilo AA. (2014 December). Breast Cancer Biomarkers: Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence. Curr Pharm Des. 20(30):4879-98.
    PubMed ID: 24283956
  • Onitilo AA, Engel JM, Salzman SA, Stankowski RV, Doi SA. R.. A core-item reviewer evaluation (CoRE) system for manuscript peer review. Account Res. 2014 November; 21(2):109-21.
    PubMed ID: 24228975
  • Stankowski-Drengler TJ, Stankowski RV, Engel JM, Onitilo AA. (2014 March). The Relationship of Type 2 Diabetes, Oral Diabetes Medications, and Insulin Therapy to Risk for Breast Cancer Curr Nutr Rep. 3(1):1-8.
  • Tanimu SB, Resnick JM, Onitilo AA. Oesophageal papillomatosis, not amenable to endoscopic therapies, treated with oesophagectomy. BMJ Case Reports. 2014 April; 2014 :pii: bcr2013200195.
    PubMed ID: 24789149
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Williams GH, Doi SA. R.. A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record. BMC Medical Informatics & Decision Making. 2014 May; 14(1):38.
    PubMed ID: 24886371
  • Rafiullah, Tanimu SB, Onitilo AA. Gangliocytic paraganglioma, a rare ampullary tumour treated with open transduodenal resection and sphincteroplasty. BMJ Case Rep. 2014 July; 2014 :pii: bcr2013202941.
    PubMed ID: 25100803
  • Onitilo AA, Engel JM, Stankowski RV, Broton M, Doi SA. R., Miskowiak D. Geographical and seasonal barriers to mammography services and breast cancer stage at diagnosis. Rural Remote Health. 2014 July; 14(3):2738.
    PubMed ID: 25018129
  • Onitilo AA, Engel JM, Stankowski RV. Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors. Ther Adv Drug Saf. 2014 August; 5(4):154-66.
    PubMed ID: 25083270
  • Dart RA, Onitilo AA, Salzman SA, Reed KD, Shukla SK. (2014 September). Ten years of Clinical Medicine & Research. Clin Med Res. 12(1-2):1.
  • Onitilo AA. (2014 September). Is it time for the cochrane collaboration to reconsider its meta-analysis methodology? Clin Med Res.. 12(1-2):2-3.
  • Liu J, Peissig PL, McCarty CA, Onitilo AA, Trentham-Dietz A, Burnside E. New genetic variants improve personalized breast cancer diagnosis. AMIA Jt Summits Transl Sci Proc.. 2014 April; eCollection 2014 :83-9.
    PubMed ID: 25717406
  • Sanfelippo MJ, Engel JM, Onitilo AA. (2014 July). Antithrombin levels are unaffected by warfarin use. Arch Pathol Lab Med.. 138(7):967-8.
    PubMed ID: 24979180
  • Stankowski RV, Engel JM, Stankowski-Drengler TJ, Liang H, Onitilo AA. (2014 September). PS2-42: All-cause Mortality is Decreased in Women Undergoing Annual Mammography Screening Before Breast Cancer Diagnosis Clinical Medicine & Research. 12(1-2):ps2-42.
  • Mankarios D, Baade P, Youl P, Mortimer R, Onitilo AA, Russell A, Doi SA. R.. Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer. ENDOCRINE. 2014 June; 46(2):300-308.
    PubMed ID: 24174176
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. Type 2 diabetes mellitus, glycemic control, and cancer risk. EUROPEAN JOURNAL OF CANCER PREVENTION. 2014 March; 23(2):134-40.
    PubMed ID: 23962874
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase. EUROPEAN JOURNAL OF CANCER PREVENTION. 2014 March; 23(2):76-83.
    PubMed ID: 23571511
  • Allen L, Yood M, Wagner E, Aiello Bowles E, Pardee R, Wellman R,...Pharmacovigilance Research Group [including Onitilo AA.] Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer. MEDICAL CARE. 2014 May; 52(5):e30-8.
    PubMed ID: 22643199
  • Feigelson HS, zeng C, Pawloski PA, Onitilo AA, Richards CS, Johnson MA,...CERGEN STeam. Does KRAS Testing in Metastatic Colorectal Cancer Impact Overall Survival? A Comparative Effectiveness Study in a Population-Based Sample. PLoS One. 2014 May; 9(5):e94977.
    PubMed ID: 24788807
  • Wu Y, Liu J, Page D, Peissig P, McCarty C, Onitilo AA, Burnside ES. Comparing the value of mammographic features and genetic variants in breast cancer risk prediction. AMIA Annu Symp Proc. 2014 November 14; 2014 :1228-37.
    PubMed ID: 25954434
  • Onitilo AA, Engel JM, Salzman-Scott SA, Stankowski RV, Doi SA. A core-item reviewer evaluation (CoRE) system for manuscript peer review. Account Res. 2014 February; 21(2):109-21.
    PubMed ID: 24228975
  • Onitilo AA. Is it time for the Cochrane Collaboration to reconsider its meta-analysis methodology? Clin Med Res. 2014 September; 12(1-2):2-3. PMCID: PMC4453299.
    PubMed ID: 24573703
  • Jamal MH, Doi SA, Moser AJ, Dumitra S, abou Khalil J, Simoneau E,...Barkun JS [including Onitilo AA.] McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinoma. World J Gastroenterol. 2014 September 14; 20(34):12226-32. PMCID: PMC4161807.
    PubMed ID: 25232256
  • Engel JM, Stankowski RV, Liang H, Doi SA. R., Onitilo AA. All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis. AJR Am J Roentgenol.. 2015 April; 204(4):898-902.
    PubMed ID: 25794084
  • Depke JL, Onitilo AA. Navigating the Needs of Rural Women with Breast Cancer: A Breast Care Program. Clin Med Res. 2015 December; 13(3-4):149-55.
    PubMed ID: 26056376
  • Onitilo AA, Engel JM, Stankowski RV, Doi SA. R.. Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy. Clinical Medicine & Research. 2015 June; 13(2):65-73.
    PubMed ID: 25487237
  • Shanle EK, Onitilo AA, Huang W, Kim K, Zang C, Engel JM,...Wisinski KB. Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer. Am J Transl Res. 2015 July 15; 7(7):1246-59.
    PubMed ID: 26328009
  • Liu J, Wu Y, Ong I, Page D, Peissig P, McCarty C,...Burnside E [including Onitilo AA.] Leveraging Interaction between Genetic Variants and Mammographic Findings for Personalized Breast Cancer Diagnosis. AMIA Jt Summits Transl Sci Proc.. 2015 March 25; 2015 :107-11.
    PubMed ID: 26306250
  • Wu Y, Abbey CK, Chen X, Liu J, Page DC, Alagoz O,...Burnside ES [including Peissig P, Onitilo AA.] (2015 August 17). Developing a utility decision framework to evaluate predictive models in breast cancer risk estimation. Journal of Medical Imaging. 2(4):041005.
  • Wu Y, Liu J, Del Rio AM, Page DC, Alagoz O, Peissig P,...Burnside ES [including Onitilo AA.] Developing a clinical utility framework to evaluate prediction models in radiogenomics. Proc SPIE Int Soc Opt Eng. 2015 February 21; 9416 PMCID: PMC4834184.
    PubMed ID: 27095854
  • Wu Y, Abbey CK, Chen X, Liu J, Page DC, Alagoz O,...Burnside ES [including Onitilo AA.] Developing a utility decision framework to evaluate predictive models in breast cancer risk estimation. J Med Imaging (Bellingham). 2015 October; 2(4):041005. PMCID: PMC4718446.
    PubMed ID: 26835489
  • Depke JL, Onitilo AA. Sexual health assessment and counseling: oncology nurses' perceptions, practices, and perceived barriers. J Community Support Oncol. 2015 December; 13(12):442-3.
    PubMed ID: 26863875
  • Fenske TS, Shah NM, Kim KM, Saha S, Zhang C, Baim AE,...Kahl BS [including Onitilo AA.] A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study. Cancer. 2015 October 1; 121(19):3465-71.
    PubMed ID: 26079295
  • Andreason M, Zhang C, Onitilo AA, Engel J, Ledesma WM, Ridolfi K,...Tevaarwerk AJ. Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result. J Community Support Oncol. 2015 May; 13(5):195-201. PMCID: PMC4511377.
    PubMed ID: 26029936
  • Doi SA, Salzman-Scott SA, Onitilo AA. Validation of the CoRE Questionnaire for Medical Journal Peer Review. Account Res. 2016 January 20; 23(1):47-52.
    PubMed ID: 26192007
  • Burnside ES, Liu J, Wu Y, Onitilo AA, McCarty CA, Page CD,...Yuan M [including Peissig PL, Kitchner T.] Comparing Mammography Abnormality Features to Genetic Variants in the Prediction of Breast Cancer in Women Recommended for Breast Biopsy. Acad Radiol. 2016 January 26; 23(1):62-9.
    PubMed ID: 26514439
  • Asare M, Peppone LJ, Roscoe JA, Kleckner IR, Mustian KM, Heckler CE,...Kamen C [including Onitilo A.] (2016 April 21). Racial Differences in Information Needs During and After Cancer Treatment: a Nationwide, Longitudinal Survey by the University of Rochester Cancer Center National Cancer Institute Community Oncology Research Program. J Cancer Educ.
    PubMed ID: 27097806
  • Doi SA, Furuya-Kanamori L, Engel JM, Jamal MH, Stankowski RV, Barkun J, Onitilo AA. The McGill Brisbane Symptom Score in relation to survival in pancreatic adenocarcinoma: a validation study. [published online ahead of print 2016 May 26]. Cancer Causes Control.
    PubMed ID: 27228990
  • Wu Y, Abbey CK, Liu J, Peissig P, Onitilo AA, Fan J,...Burnside ES. Discriminatory power of common genetic variants in personalized breast cancer diagnosis. Proc SPIE Int Soc Opt Eng. 2016 February 27; 9787
    PubMed ID: 27279675
  • Garg MK, Zhao F, Lee J, Sparano J, Palefsky J, Henry D,...Kachnic LA [including Onitilo A.] (2016 October 1). Radiation Therapy Compliance/Quality Assurance (QA) in 2 Phase 2 Trials of Cetuximab Plus Combined Modality Therapy (CMT) Including Chemotherapy and Radiation Therapy (RT) for Patients With Squamous Cell Carcinoma of the Anal Canal (SCCAC) (AMC045). Int J Radiat Oncol Biol Phys. 96(2S):S106-S107.
    PubMed ID: 27675537
  • Yellu MR, Engel JM, Ghose A, Onitilo AA. Overview of recent trends in diagnosis and management of leptomeningeal multiple myeloma. Hematol Oncol. 2016 March; 34(1):2-8.
    PubMed ID: 25524637
  • Garg MK, Zhao F, Sparano JA, Palefsky J, Whittington R, Mitchell EP,...Benson AB [including Onitilo AA.] Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205). J Clin Oncol. 2017 March; 35(7):718-726.
    PubMed ID: 28068178
  • Potugari BR, Engel JM, Onitilo AA. Metastatic Prostate Cancer in a RAD51C Mutation Carrier. Clin Med Res. 2018 December; 16(3-4):69-72.
    PubMed ID: 30587560
  • Feld SI, Woo KM, Alexandridis R, Wu Y, Liu J, Peissig P,...Burnside ES [including Onitilo AA.] Improving breast cancer risk prediction by using demographic risk factors, abnormality features on mammograms and genetic variants. AMIA Annu Symp Proc. 2018 December 5; 2018 :1253-1262.
    PubMed ID: 30815167
  • Furuya-Kanamori L, Sedrakyan A, Onitilo AA, Bagheri N, Glasziou P, Doi SAR. Differentiated thyroid cancer: millions spent with no tangible gain? Endocr. Relat. Cancer. 2018 January; 25(1):51-57.
    PubMed ID: 29042396
  • Ruddy KJ, Le-Rademacher J, Lacouture ME, Wilkinson M, Onitilo AA, Vander Woude AC,...Loprinzi CL. Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial. [published online ahead of print 2019 September 19]. Breast. 48 :89-97. doi: 10.1016/j.breast.2019.09.011.
    PubMed ID: 31590108
  • Mani H, Safo P, Onitilo AA. Linagliptin-associated bullous pemphigoid treated with rituximab. BMJ Case Rep. 2019 September 30; 12(9)doi: 10.1136/bcr-2019-229902 . PMCID: PMC6768351 .
    PubMed ID: 31570343
  • Tanimu S, Williams C, Onitilo AA. Small-bowel obstruction from Gorilla Glue ingestion. Gastrointest Endosc. 2019 August; 90(2):308-309. doi: 10.1016/j.gie.2019.04.199.
    PubMed ID: 30959029
  • Kleckner IR, Kamen C, Cole C, Fung C, Heckler CE, Guido JJ,...Mustian KM [including Onitilo AA.] Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial. Support Care Cancer. 2019 December; 27(12):4615-4625. PMCID: PMC6774911.
    PubMed ID: 30937600
  • Yao S, Hu Q, Kerns S, Yan L, Onitilo AA, Misleh J,...Janelsins MC. Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study. Clin Epigenetics. 2019 March 12; 11(1):45. doi: 10.1186/s13148-019-0641-1. PMCID: PMC6416954.
    PubMed ID: 30867049
  • Asare M, Heckler CE, Culakova E, Kamen CS, Kleckner AS, Minasian LM,...Janelsins MC [including Onitilo AA.] Racial/Ethnic Differences in Comprehension of Biospecimen Collection: a Nationwide University of Rochester Cancer Center NCI Community Oncology Research Program Study. [published online ahead of print 2019 January 5]. J Cancer Educ. PMCID: PMC6612536.
    PubMed ID: 30612315
  • Furuya-Kanamori L, Doi SA, Onitilo A, Akhtar S. Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors? [published online ahead of print 2019 November 7]. Expert Opin Drug Saf.
    PubMed ID: 31698959
  • Onitilo, A., Wall, D., Engelien, S. Barriers to Clinical Trial Enrollment-Part I. [published online ahead of print 2019 August]. The Cancer Letter. 45(31)
  • Onitilo, A., Wall, D., Engelien, S. Measures to improve clinical trial enrollment: Marshfield Clinic Cancer Care and research approach-Part II. [published online ahead of print 2019 August]. The Cancer Letter. 45(34)
  • Loh KP, Mohile SG, Lund JL, Epstein R, Lei L, Culakova E,...Duberstein P [including Onitilo A.] Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists. Oncologist. 2019 June; 24(6):e292-e302. PMCID: PMC6656513.
    PubMed ID: 31015317
  • Onitilo AA, Wittig JA. Principles of Immunotherapy in Melanoma. Surg Clin North Am. 2020 February; 100(1):161-173.
    PubMed ID: 31753110
  • Michael Sheehan, Sabo Tanimu, Yusuf Tanimu, Jessica Engel, Adedayo Onitilo. Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review. Case Reports in Oncology. 2020 March 25; 13 doi: 10.1159/000506100. PMCID: PMC7154241.
  • Busari JO, Onitilo AA. Fact or Fable: The Truth about Physician Engagement and Burnout. Clin Med Res. 2020 March; 18(1):1-2. PMCID: PMC7153798.
    PubMed ID: 31959672
  • Sheehan MT, Wermers RA, Jatoi A, Loprinzi CL, Onitilo AA. Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy. Med Hypotheses. 2020 October;143:110149. doi: 10.1016/j.mehy.2020.110149.
    PubMed ID: 32763659
  • Sheehan M, Tanimu S, Tanimu Y, Engel J, Onitilo A. Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review. Case Rep Oncol. 2020 March; 13(1):321-329. PMCID: PMC7154241.
    PubMed ID: 32308599
  • Connolly RM, Zhao F, Miller KD, Lee MJ, Piekarz RL, Smith KL,...Sparano JA [including Onitilo AA.] E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group. J Clin Oncol. 2021 October 1; 39(28):3171-3181. PMCID: PMC8478386.
    PubMed ID: 34357781
  • Joseph AO, Li YH, Salako O, Doi S, Balogun OD, Awofeso OM,...Onitilo AA. A review of breast cancer pathology reports in Nigeria. Ecancermedicalscience. 2021 February 23;15:1190. doi: 10.3332/ecancer.2021.1190. PMCID: PMC8043685.
    PubMed ID: 33889199
  • Onitilo AA, Engel J, Joseph AO, Li YH. Is oestrogen receptor-negative/progesterone receptor-positive (ER-/PR+) a real pathological entity? Ecancermedicalscience. 2021 August 24; 15 :1278. doi: 10.3332/ecancer.2021.1278. PMCID: PMC8426004.
    PubMed ID: 34567263
  • Onitilo AA, Stankowski-Drengler TJ, Shiyanbola O, Engel J, Tanimu S, Fagbemi SO, Li YH. Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC). Clin Med Res. 2021 June; 19(2):64-71. PMCID: PMC8231693.
    PubMed ID: 33789952
  • Sheehan MT, Li YH, Doi SA, Onitilo AA. Frequency of Parathyroid Hormone Assessment in the Evaluation of Hypercalcemia. A Comparison Between Patients With and Without a History of Malignancy in a 20-year Dataset of 20,954 Patients. Clin Med Insights Endocrinol Diabetes. 2021 November 24;14:11795514211059494. doi: 10.1177/11795514211059494. PMCID: PMC8637696.
    PubMed ID: 34866958
  • Sheehan MT, Li YH, Doi SA, Onitilo AA. Evaluation of Diagnostic Workup and Etiology of Hypercalcemia of Malignancy in a Cohort of 167 551 Patients Over 20 Years. J Endocr Soc. 2021 October 6;5(11):bvab157. doi: 10.1210/jendso/bvab157. PMCID: PMC8533987.
    PubMed ID: 34703961
  • Tevaarwerk AJ, Kwekkeboom K, Buhr KA, Dennee A, Conkright W, Onitilo AA,...Sesto ME. Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisconsin Oncology Network study. Cancer. 2021 March 1; 127(5):801-808. PMCID: PMC7945680.
    PubMed ID: 33231882
  • Onitilo AA, Piwuna TO, Islam N, Furuya-Kanamori L, Kumar S, Doi SAR. Determinants of Atrial Fibrillation Development among Patients undergoing Ibrutinib Therapy. Clin Med Res. 2022 March;20(1):16-22. doi: 10.3121/cmr.2021.1693. PMCID: PMC9390851.
    PubMed ID: 35022197
  • Doi SAR, Bashir M, Sheehan MT, Onitilo AA, Chivese T, Ibrahim IM,...McIntyre HD. Unifying the diagnosis of gestational diabetes mellitus: Introducing the NPRP criteria. Prim Care Diabetes. 2022 February 16; 16(1):96-101. doi: 10.1016/j.pcd.2021.08.006.
    PubMed ID: 34419366
  • Joseph A, Olatosi B, Haider MR, Adegboyega BC, Lasebikan NN, Aliyu UM,...Onitilo AA. Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in Nigeria. JCO Glob Oncol. 2022 February;8:e2100244. doi: 10.1200/GO.21.00244. PMCID: PMC8853626.
    PubMed ID: 35157511
  • Kleckner AS, Kleckner IR, Culakova E, Shayne M, Belcher EK, Gudina AT,...Janelsins MC [including Onitilo AA.] The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6 months post-chemotherapy. Support Care Cancer. 2022 September; 30(9):7655-7663. PMCID: 3314239.
    PubMed ID: 35678881
  • Gilmore N, Xu H, Kehoe L, Kleckner AS, Moorthi K, Lei L,...Mohile SG [including Onitilo AA.] Evaluating the association of frailty with communication about aging-related concerns between older patients with advanced cancer and their oncologists. Cancer. 2022 March 1; 128(5):1101-1109. PMCID: PMC8837685.
    PubMed ID: 34762734
  • Bradbury AR, Lee JW, Gaieski JB, Li S, Gareen IF, Flaherty KT,...Wagner LI [including Onitilo AA.] A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152). Cancer. 2022 April 1; 128(7):1381-1391. PMCID: PMC8917095.
    PubMed ID: 34890045
  • Shour AR, Anguzu R, Zhou Y, Muehlbauer A, Joseph A, Oladebo T,...Onitilo AA [including Puthoff D.] Your neighborhood matters: an ecological social determinant study of the relationship between residential racial segregation and the risk of firearm fatalities. BioMed Central Injury Epidemiology Journal. 2023 March 13; 10(14)doi: 10.1186/s40621-023-00425-w. PMCID: PMC10012477.
    PubMed ID: 36915201
  • Patel SP, Othus M, Chen Y, Wright GP, Yost KJ, Hyngstrom JR,...Onitilo AA. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma. N Engl J Med. 2023 March 2; 388(9):813-823.
    PubMed ID: 36856617
  • Tomlins SA, Khazanov NA, Bulen BJ, Hovelson DH, Shreve MJ, Lamb LE,...Rhodes DR [including Onitilo AA.] Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit. Commun Med (Lond). 2023 February 7; 3(1):14. PMCID: PMC9905474.
    PubMed ID: 36750617
  • Joseph A, Shour AR, Lasebikan NN, Jimoh MA, Adegboyega BC, Nwachukwu E,...Onitilo AA [including Puthoff D.] Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics. JCO Glob Oncol. 2023 March;9:e2200221. doi: https://doi.org/10.1200/go.22.00221. PMCID: PMC10497253.
    PubMed ID: 36921242
  • Onitilo AA, Shour AR, Puthoff DS, Tanimu Y, Joseph A, Sheehan MT. Evaluating the adoption of voice recognition technology for real-time dictation in a rural healthcare system: A retrospective analysis of dragon medical one. PLoS One. 2023 March;18(3):e0272545. doi: 10.1371/journal.pone.0272545. PMCID: PMC10035815.
    PubMed ID: 36952436
  • Shour A, onitilo AA, Anguzu R. The impact of minority health social vulnerability on population-based cancer incidence. [published online ahead of print 2023 May 25]. JOURNAL OF CLINICAL ONCOLOGY. 41(16):e22501. doi: 10.1200/JCO.2023.41.16\_suppl.e22501.
  • Navari RM, Le-Rademacher J, Smieliauskas F, Ruddy KJ, James Saphner T, Liu H,...Loprinzi CL [including Onitilo AA.] Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602). [published online ahead of print 2023 June 7]. Oncologist. doi: 10.1093/oncolo/oyad140.
    PubMed ID: 37284847
  • Bulen BJ, Khazanov NA, Hovelson DH, Lamb LE, Matrana M, Burkard ME,...Tomlins SA [including Onitilo AA.] Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit. Cancer Res Commun. 2023 July; 3(7):1335-1349. doi: 10.1158/2767-9764.CRC-23-0036. PMCID: PMC10367935.
    PubMed ID: 37497337
  • Unger JM, Stires H, Levit LA, Stewart M, McKelvey BA, Canin B,...Schenkel C [including Onitilo AA.] Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality. JCO Oncol Pract. 2023 October;19(10):907-916. doi: 10.1200/OP.23.00185. PMCID: PMC10615547.
    PubMed ID: 37643386
  • Shour AR, Jones GL, Anguzu R, Doi SA, Onitilo AA. Development of an evidence-based model for predicting patient, provider, and appointment factors that influence no-shows in a rural healthcare system. BMC Health Serv Res. 2023 September 14; 23(1):989. doi: 10.1186/s12913-023-09969-5. PMCID: PMC10503036.
    PubMed ID: 37710258
  • Joseph A, Akinsete A, Adeneye S, Balogun O, Awofeso O, Oladipo A,...Onitilo AA [including Puthoff D, Shour A.] Feasibility and Safety of Implementing Volumetric Arc Therapy (VMAT) for Pediatric Craniospinal Irradiation in a Low-Middle-Income Region: The Nigerian Experience. Advances in Radiation Oncology. 2023 July 28; :101325. doi: 10.1016/j.adro.2023.101325.
  • Shour A, Onitilo AA. Distance Matters: Investigating No-Shows in a Large Rural Provider Network. Clin Med Res. 2023 December;21(4):177-191. doi: 10.3121/cmr.2023.1853.
    PubMed ID: 38296643
  • AbdulMajeed J, Khatib M, Dulli M, Sioufi S, Al-Khulaifi A, Stone J,...Doi SAR [including Onitilo AA.] Use of conditional estimates of effect in cancer epidemiology: An application to lung cancer treatment. Cancer Epidemiol.. 2024 February;88:102521. doi: 10.1016/j.canep.2023.102521.
    PubMed ID: 38160570
  • Joseph A, Akinsete AM, Lasebikan NN, Adeneye S, Awofeso OM, Oladipo AT,...Onitilo AA [including Puthoff DS.] The Landscape of Pediatric Radiation Oncology in Nigeria. JCO Glob Oncol. 2024 January;10:e2300219. doi: 10.1200/GO.23.00219. PMCID: PMC10793986.
    PubMed ID: 38207247
  • Tanimu Y, Coombs R, Tanimu S, Onitilo A. Association of Programmed Cell Death 1 Inhibitor with Circumorificial Plasmacytosis. Case Rep Oncol. 2024 January 5;17(1):33-38. doi: 10.1159/000535015. PMCID: PMC10769499.
    PubMed ID: 38188483
  • Tanimu S, Coombs RA, Tanimu Y, Onitilo AA. Cholecystectomy clip-induced biliary stone: Case report and literature review. [published online ahead of print 2024 February 9]. J Minim Access Surg. doi: 10.4103/jmas.jmas_323_23.
    PubMed ID: 38340083
  • McBane RD, Loprinzi CL, Zemla T, Tafur A, Sanfilippo K, Liu JJ,...Wysokinski WE [including Onitilo AA.] Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial. [published online ahead of print 2024 March 25]. J Thromb Haemost. doi: 10.1016/j.jtha.2024.03.011.
    PubMed ID: 38537780
  • Musa OAH, Syed A, Khatib MA, Hamdan A, Hub Allah A, Almahdi H,...Doi SA [including Onitilo AA, Sheehan MT.] Time to Move Beyond a Binary Criterion for Gestational Diabetes? Reprod Sci. 2024 July;31(7):2073-2079. doi: 10.1007/s43032-024-01514-x.
    PubMed ID: 38485893
  • Wu CC, Bassi A, Onitilo A, Sharma R. Intra-Operative Diagnosis of Benign Multicystic Peritoneal Mesothelioma: A Case Report of Rare Entity and Lessons Learned. Cureus. 2024 May 20;16(5):e60664. doi: 10.7759/cureus.60664. PMCID: PMC11186218.
    PubMed ID: 38899248
  • Singhal S, Wang Y, Qin Z, Peterson DR, Dunne RF, Culakova E,...Loh KP [including Onitilo A.] Nutritional impairment, psychological health and quality of life among older adults with advanced cancer: A secondary analysis of a randomized clinical trial. Cancer Med. 2024 June;13(12):e7348. doi: 10.1002/cam4.7348. PMCID: PMC11187162.
    PubMed ID: 38898664
  • Joseph A, Shour AR, Lasebikan NN, Jimoh MA, Adegboyega BC, Nwachukwu E,...Onitilo AA [including Puthoff D.] COVID-19-Related Treatment Cancellations and Oncology Patients' Psychological Health in Nigeria. Clin Med Res. 2024 June;22(2):61-75. doi: 10.3121/cmr.2024.1854. PMCID: PMC11374496.
    PubMed ID: 39231622
  • Saracino RM, Kehoe LA, Sohn MB, Wang L, Mohile S, Wells M,...McConnell KM [including Onitilo A.] Psychometric Properties of the Generalized Anxiety Disorder Scale (GAD-7) in Older Adults With Advanced Cancer. Psychooncology. 2024 November;33(11):e70012. doi: 10.1002/pon.70012.
    PubMed ID: 39482282